Literature DB >> 16258272

What is the role of tubular epithelial cell apoptosis in polycystic kidney disease (PKD)?

Charles L Edelstein1.   

Abstract

Tubular epithelial cell apoptosis occurs in most animal models of polycystic kidney disease (PKD) and in kidneys from humans with autosomal dominant polycystic kidney disease (ADPKD). Induction of apoptosis in cultured tubular epithelial cells results in cyst formation. Induction of apoptosis in the kidney in Bcl-2 deficient mice results in increased proliferation of tubular epithelium and cyst formation. Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in the Han:SPRD rat model of PKD. Thus, there is evidence that both epithelial cell apoptosis and proliferation are dysregulated in ADPKD and may represent a general mechanism for cyst growth.

Entities:  

Mesh:

Year:  2005        PMID: 16258272     DOI: 10.4161/cc.4.11.2185

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  24 in total

1.  2-Hydroxyestradiol slows progression of experimental polycystic kidney disease.

Authors:  Sharon Anderson; Terry T Oyama; Jessie N Lindsley; William E Schutzer; Douglas R Beard; Vincent H Gattone; Radko Komers
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-07

2.  Hypoxia-inducible factor-1α (HIF-1α) and autophagy in polycystic kidney disease (PKD).

Authors:  Franck Belibi; Iram Zafar; Kameswaran Ravichandran; Anamarija Bauer Segvic; Alkesh Jani; Danica Galesic Ljubanovic; Charles L Edelstein
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-26

3.  Smac-mimetic-induced epithelial cell death reduces the growth of renal cysts.

Authors:  Lucy X Fan; Xia Zhou; William E Sweeney; Darren P Wallace; Ellis D Avner; Jared J Grantham; Xiaogang Li
Journal:  J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 10.121

4.  Caspase-3 gene deletion prolongs survival in polycystic kidney disease.

Authors:  Yunxia Tao; Iram Zafar; Jun Kim; Robert W Schrier; Charles L Edelstein
Journal:  J Am Soc Nephrol       Date:  2008-02-13       Impact factor: 10.121

5.  An mTOR anti-sense oligonucleotide decreases polycystic kidney disease in mice with a targeted mutation in Pkd2.

Authors:  Kameswaran Ravichandran; Iram Zafar; Zhibin He; R Brian Doctor; Radu Moldovan; Adam E Mullick; Charles L Edelstein
Journal:  Hum Mol Genet       Date:  2014-05-08       Impact factor: 6.150

6.  The consequences of increased 4E-BP1 in polycystic kidney disease.

Authors:  Sara J Holditch; Carolyn N Brown; Daniel J Atwood; Deepak Pokhrel; Sara E Brown; Andrew M Lombardi; Khoa N Nguyen; Ryan C Hill; Miguel Lanaspa; Katharina Hopp; Mary C M Weiser-Evans; Charles L Edelstein
Journal:  Hum Mol Genet       Date:  2019-12-15       Impact factor: 6.150

7.  An mTOR kinase inhibitor slows disease progression in a rat model of polycystic kidney disease.

Authors:  Kameswaran Ravichandran; Iram Zafar; Abdullah Ozkok; Charles L Edelstein
Journal:  Nephrol Dial Transplant       Date:  2014-09-19       Impact factor: 5.992

8.  Antisense-mediated angiotensinogen inhibition slows polycystic kidney disease in mice with a targeted mutation in Pkd2.

Authors:  Kameswaran Ravichandran; Abdullah Ozkok; Qian Wang; Adam E Mullick; Charles L Edelstein
Journal:  Am J Physiol Renal Physiol       Date:  2014-12-23

9.  Ectopic expression of Cux1 is associated with reduced p27 expression and increased apoptosis during late stage cyst progression upon inactivation of Pkd1 in collecting ducts.

Authors:  Binu M Paul; Dianne Vassmer; Aaron Taylor; Lynn Magenheimer; Carol G Carlton; Klaus B Piontek; Gregory G Germino; Gregory B Vanden Heuvel
Journal:  Dev Dyn       Date:  2011-04-04       Impact factor: 3.780

10.  Mechanoprotection by polycystins against apoptosis is mediated through the opening of stretch-activated K(2P) channels.

Authors:  Rémi Peyronnet; Reza Sharif-Naeini; Joost H A Folgering; Malika Arhatte; Martine Jodar; Charbel El Boustany; Claire Gallian; Michel Tauc; Christophe Duranton; Isabelle Rubera; Florian Lesage; York Pei; Dorien J M Peters; Stefan Somlo; Frederick Sachs; Amanda Patel; Eric Honoré; Fabrice Duprat
Journal:  Cell Rep       Date:  2012-03-08       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.